Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer.
about
Tamoxifen Resistance: Emerging Molecular TargetsDifferences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implicationsMolecular Portrait of the Normal Human Breast Tissue and Its Influence on Breast CarcinogenesisSoy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future PerspectivesAberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerClinical significance of estrogen receptor β in breast and prostate cancer from biological aspectsA transgenic mouse model expressing an ERα folding biosensor reveals the effects of Bisphenol A on estrogen receptor signaling.Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis.Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancerMolecular drivers of lobular carcinoma in situ.Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression.Ligand Independent and Subtype-Selective Actions of Thyroid Hormone Receptors in Human Adipose Derived Stem Cells.ERβ expression and breast cancer risk prediction for women with atypias.A summary of relationships between alternative splicing and breast cancer.Bioanalytical LC-MS Method for the Quantification of Plasma Androgens and Androgen Glucuronides in Breast Cancer.ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function.The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System.New insights into estrogenic regulation of O6-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O6-benzylguanine indicates fresh avenues for therapy.Dysregulation of Notch and ERα signaling in AhR-/- male mice.Emerging Estrogenic Pollutants in the Aquatic Environment and Breast Cancer.ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer.A thermal gradient modulates the oxidative metabolism and growth of human keratinocytes.Evaluation of the effect of the new methoxy-stilbenes on expression of receptors and enzymes involved in estrogen synthesis in cancer breast cells.The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling.Quantitative mapping of RNA-mediated nuclear estrogen receptor β interactome in human breast cancer cells.Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesisKey regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer
P2860
Q26739969-65793D92-FFEE-468B-8BDB-AE2AA5AAF619Q26740072-27C13FB9-E641-4E0C-99BC-933DA4AB2255Q26744296-336D3880-E4C4-4A66-B10B-DA7B3221A37AQ26772042-34A08A20-34E7-4B5A-A7E2-DBCF89021672Q26773907-CCF101EA-AC8F-443B-B454-EA9B21526D86Q28087001-81FD18A1-81B7-4DBA-98F9-3C0E6A3372ACQ30819855-B73E5E04-9514-4890-96AF-AD0DD11AB44BQ33864656-53101B54-B812-4719-81A1-7E7D34022CF9Q34315419-B59CDA36-EF72-4089-A8AE-81C4ADEF2A8DQ34334131-B29CA616-7452-4731-A015-E1229B4FBD77Q35676504-1DADCDC3-0933-4DC2-A367-B75BEC1FAABBQ35998828-CDA7D65C-7E14-4A69-9A03-8A5F741403D6Q36030868-D8A38038-BBB7-4088-86A9-B3769A569D48Q36161537-FA75C03E-AA26-4E83-B715-3BCB724A250BQ36248899-5DCBEF4A-DF8B-4728-BAF1-0CBFC6235E78Q36378283-D9D94ADB-74B1-4473-8CD2-5353E08911CFQ36947561-5DE6EE26-CF5B-4BAA-9893-47AE8291C0ABQ37046414-356A55F2-A7B1-4548-9A8D-859E73FB4EFDQ37234859-A52B066A-AF50-45C3-A576-1D815ABBD447Q37300127-A8FC661A-01A4-4A23-A584-1540D9C56158Q37369446-02930F4C-5A6C-45A4-9F23-A26D68FBBD61Q41673566-F5AB38D6-5B37-4C58-9C7F-4D3503A89137Q41674321-745DCD4B-81DE-4E9C-A100-49124C757FB8Q47123258-3F5F572C-EE60-4F94-9B6D-11AC2CDAD0A5Q47347584-40BD52E7-EC5C-4A63-A21A-5FBE8C41C024Q52649598-23AF55A5-1F7C-4937-85B2-F0A62B90039CQ55238833-0E2796A8-CE71-444D-9D42-73B557615F0CQ57112840-49C69EEB-B63B-4811-8FFE-AE7C52263265Q58765163-F39D5B47-EDE0-4DC6-A169-4484B3E025BC
P2860
Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Differential expression of est ...... ular and ductal breast cancer.
@en
Differential expression of est ...... ular and ductal breast cancer.
@nl
type
label
Differential expression of est ...... ular and ductal breast cancer.
@en
Differential expression of est ...... ular and ductal breast cancer.
@nl
prefLabel
Differential expression of est ...... ular and ductal breast cancer.
@en
Differential expression of est ...... ular and ductal breast cancer.
@nl
P2093
P2860
P356
P1476
Differential expression of est ...... ular and ductal breast cancer.
@en
P2093
Aleksandra Filipovic
Hiroko Yamashita
Hirotaka Iwase
Jan-Åke Gustafsson
Raoul Charles Coombes
Tatsuya Toyama
Yoko Omoto
P2860
P304
P356
10.1073/PNAS.1323719111
P407
P577
2014-01-21T00:00:00Z